Articles published in Journal of Stem Cell Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Stem Cell Research & Therapy has got h-index 26, which means every article in Journal of Stem Cell Research & Therapy has got 26 average citations.

Following are the list of articles that have cited the articles published in Journal of Stem Cell Research & Therapy.

  2022 2021 2020 2019 2018

Year wise published articles

59 65 23 13 36

Year wise citations received

351 405 380 349 319
Journal total citations count 3118
Journal Impact Factor 1.64
Journal 5 years Impact Factor 1.70
Journal CiteScore 11.56
Journal h-index 26
Important citations

Alcohol and Cancer Stem Cells

Alcohol and Cancer Stem Cells

In Vivo Outcome of Homology-Directed Repair at the HBB Gene in HSC Using Alternative Donor Template Delivery Methods

Impact of perioperative pain management on cancer recurrence: an ASRA/ESRA special article

The role of TRIM family proteins in the regulation of cancer stem cell self-renewal

The role of TRIM family proteins in the regulation of cancer stem cell self-renewal

Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein

Editing the sickle cell disease mutation in human hematopoietic stem cells: comparison of endonucleases and homologous donor templates

Hypoxia Induces the Acquisition of Cancer Stem-like Phenotype Via Upregulation and Activation of Signal Transducer and Activator of Transcription-3 (STAT3) in MDA-MB-231, a Triple Negative Breast Cancer Cell Line

Increased Cellular Levels of MicroRNA-9 and MicroRNA-221 Correlate with Cancer Stemness and Predict Poor Outcome in Human Breast Cancer

Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I

Editing a ?-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype

Lentiviral and genome-editing strategies for the treatment of ?-hemoglobinopathies

The delivery challenge: fulfilling the promise of therapeutic genome editing

Priming human repopulating hematopoietic stem and progenitor cells for Cas9/sgRNA gene targeting

Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives

Correction to: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing

Disruption of the BCL11A erythroid enhancer reactivates fetal hemoglobin in erythroid cells of patients with ?-thalassemia major

 Cyclosporine H overcomes innate immune restrictions to improve lentiviral transduction and gene editing in human hematopoietic stem cells

Tregopathies: monogenic diseases resulting in regulatory T-cell deficiency